Production & Manufacturing
News
Indian Pharma Grows 8% CAGR, Surpassing Global Average
The Indian pharma sector has seen 8% CAGR growth and at the same time has witnessed a 9% rise when it comes to export rates in 2024, as per one of the reports. McKinsey & Company’s report has shown...
Drug Research
LINDIS Biotech Partners with Celonic for Production and Commercial Supply of Catumaxomab
LINDIS Biotech has received EMA Marketing Authorisation for catumaxomab, making it the only medicine licensed for the targeted and cancer-directed therapy of malignant ascites.
Celonic Group will produce catumaxomab for commercial use.
Catumaxomab will be manufactured at Celonic's...
Press Releases
New Syngene biologics manufacturing facility to be operational for US and European customers from mid-year
At DCAT 2024 global bio/pharmaceutical manufacturing forum, Syngene International, a global contract research, development and manufacturing organization (CRDMO), will announce that its newly upgraded biologics facility - Unit 3 - would be operational for clinical and commercial supply in...
News
ST Pharm breaks ground on 2nd oligonucleotide manufacturing plant
ST Pharm said it has taken its first step towards becoming the global leader in the oligonucleotide contract development and manufacturing organization (CDMO) domain with the groundbreaking ceremony for its second oligonucleotide facility.
The new plant will be located in...
BioPharma
Elevating Biopharmaceutical Projects With The Right CDMO
In the biopharma industry, selecting the right contract development and manufacturing organization (CDMO) is pivotal to a successful pharmaceutical development journey. This decision hinges on two critical factors: a customer-centric approach and team cohesion. In this blog, we explore...
News
Biovian announces over €50 million investment in manufacturing facility in Turku, Finland
Biovian, a leading contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, has announced a major investment of over €50 million to expand its manufacturing facility in Turku, Finland.
This investment reflects Biovian’s commitment to meeting the growing demand for...
News
New PAT – Based Strategy Stops Membrane Fouling In SP – TFF
A recent article published in the Journal of Membrane Science presents a new approach for implementing a robust single-pass tangential flow filtration (SP-TFF) operation in biomanufacturing. The authors introduce a process analytical technology (PAT)-based strategy that integrates and continuously...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
